Use of 0.5% apraclonidine solution in evaluation of blepharoptosis

Yazici B., Beden U.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, vol.24, no.4, pp.299-301, 2008 (SCI-Expanded) identifier identifier identifier


Purpose: To evaluate the effect of instillation of a specific alpha 2-adrenergic agonist, topical 0.5% apraclonidine solution, on upper eyelid position in patients with blepharoptosis.